UK cost group rules against Exubera
Pfizer’s inhaled insulin, Exubera, should not be prescribed by Britain’s state health service, the country’s National Institute for Health and ...
Your Email Address: *
Recipient(s) Email Address: *
(Separate multiple e-mail addresses with commas. Limited to 20 addresses.)
Your message:
The e-mail address(es) that you supply to use this service will only be used to send the requested article.